Akara Group International Japan informs investors that AT&T, Inc. (T) shares will commence trading ex-dividend on April 6th, implying that the telecoms giant is set for a lengthy period of stagnation.

Celgene Corp. (CELG) continues as Akara Group's biotech recommendation list as the recent sell-off positions the stock as attractive at current levels.